This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
protagonist therapeutics
NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings.
Jefferies Global Healthcare Conference – June 3-5, 2025
About Protagonist Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides, icotrokinra and rusfertide, derived from Protagonist’s proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA expected in 2025. Icotrokinra (JNJ-2113) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor (“IL-23R”) which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra’s joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies’ IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage oral drug discovery programs addressing clinically and commercially validated targets, including the IL-17 oral peptide antagonist PN-881, an oral hepcidin program, and an oral obesity program.
More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company’s website at www.protagonist-inc.com.
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media
Noblie expands its U.S. shop, boosting capacity and models. More custom blades with shorter lead times – folding, EDC, hunting, chef, and collector’s models. Performance…
States and municipalities increasingly require OSHA 10 and 30 training for construction, entertainment, and cannabis work, creating overlooked compliance risks. Ignoring mandatory OSHA 10- and…
This escape features Trellis Spa indulgence, early arrival, welcome cocktails, and a nightly $200 spa credit. HOUSTON, TX, UNITED STATES, January 26, 2026 /EINPresswire.com/ —…
L’École de Naturopathie et Sophrologie publie un guide sur la naturopathie animale destiné aux passionnés souhaitant améliorer le bien-être de leur chien. Ce guide gratuit…
A Bold Return Thirsting For Light, Growth & Hope Listen Here LONDON, UK / MusicWire / Jan. 23, 2026 — Singer-songwriter Parson James, the genre-blending…
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused…
ARS Roofing & Gutters earns 2025 Best Places to Work, celebrating an inclusive culture, strong teamwork, and community impact across the North Bay. …for them…
Online Sales Counselors continue to perform as adoption declines Speed matters, but structure matters more. OSCs bridge the gap between marketing and onsite sales by…
New solution focuses on documentation, verification, and defensibility of consumer leads PHOENIX, AZ, UNITED STATES, January 23, 2026 /EINPresswire.com/ — FormClue.io announced the launch of…
ANAHEIM, CA, UNITED STATES, January 23, 2026 /EINPresswire.com/ — SK Labs, a contract manufacturer specializing in dietary supplement capsules, tablets, and powders, has earned NSF/ANSI…
ATLANTA, GA – January 23, 2026 – PRESSADVANTAGE – Arrowhead Clinic Chiropractor Atlanta has strengthened its collaborative approach with leading personal injury attorneys throughout the…
Expanding Gold and Critical Elements in the Mineral-Rich Province of New Brunswick, Canada MIRAMICHI, NB / ACCESS Newswire / January 23, 2026 / SLAM Exploration…
YUEQING, ZHEJIANG, CHINA, January 23, 2026 /EINPresswire.com/ — WENZHOU, CHINA — As we move into 2026, the global industrial landscape is witnessing a profound shift…
Azalea Med Spa is a sanctuary for balance, confidence, and holistic well-being. We’re proud of this space and grateful for Clockwork’s thoughtful vision in bringing…
MALDIVES, January 23, 2026 /EINPresswire.com/ — Cinnamon Hotels & Resorts Maldives has introduced a limited-time flash offer for March 2026, providing travellers with savings of…
Study Highlights the Efficacy of PMC in Suppressing Non-Small Cell Lung Cancer Growth SEOUL, SOUTH KOREA, January 23, 2026 /EINPresswire.com/ — A South Korean research…
New dual-mechanism designs and advanced wellness AI demonstrate continued innovation in the premium massage chair category. technology should never overshadow the fundamental value of a…
CINCINNATI, OH – January 22, 2026 – PRESSADVANTAGE – Dr. Mark Mandell-Brown of the Mandell-Brown Plastic Surgery Center has been recognized by three Cincinnati publications…
Musician, meditation teacher, actor (True Detective, Rambo), now fiction writer, Jake La Botz to release book and play music at tattoo shops around the world….
A Bold Return Thirsting For Light, Growth & Hope Listen Here LONDON, UK / MusicWire / Jan. 23, 2026 — Singer-songwriter Parson James, the genre-blending…
VINEMONT, AL, UNITED STATES, January 22, 2026 /EINPresswire.com/ — Seasoned Compliance Leader, Author, and Advocate Dedicated to Safety, Faith, and the People Behind the Wheel…
Performance starts here. Since 1976. MORRISVILLE, VT, UNITED STATES, January 22, 2026 /EINPresswire.com/ — Concept2®, the global leader in rowing oars and fitness equipment, celebrates…
Funding will accelerate product development and rollout for manufacturers, distributors, and retailers struggling with lost sales and unproductive inventory. ATLANTA, GA, UNITED STATES, January 22,…
